Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Guest article

In a tough regulatory climate being forewarned is forearmed, says ISI Europe

17-Mar-2011 - Don’t think of the global regulatory information clampdown as a burden. It’s an opportunity to put your house in order, says Adam Sherlock, MD of ISI Europe.

Pfizer may sell non-core units according to analyst

15-Mar-2011 - US drug giant Pfizer may sell its generics, consumer health and Capsugel units in an effort to slim down and refocus on its core pharmaceutical business according to a number...

Study questions $1.3bn average R&D cost per new drug

01-Mar-2011 - New research has questioned the widely accepted $1.3bn average cost of R&D per new drug, claiming it is an overestimate and an obstacle.

Capsugel buys FlexTab to expand into high value markets

17-Feb-2011 - Pfizer’s Capsugel unit has bought an injection molding technology that, it believes, will expand its capsule filling business into new “high value segments.”

Sanofi to buy Genzyme for $20.1bn and performance-based CVR

16-Feb-2011 - French drugmaker Sanofi Aventis will buy Genzyme after the firms finally agree a valuation based on manufacturing performance, approvals and sales.

Novasep and instrAction team on taxane process development

09-Feb-2011 - Novasep and instrAction have partnered to develop improved methods for the production of taxane-based active pharmaceutical ingredients (API) citing growing demand for cancer treatments as key driver.

INC aims to bolster consulting arm with Avos acquisition

18-Jan-2011 - US CRO INC Research has bought industry consulting group Avos Life Sciences, citing pharma clients’ need to maximize return on R&D and minimize risk as the key driver.

Indian cultural diversity affects attitudes to pharma packaging

10-Jan-2011 - Cultural diversity within India underpins differing attitudes to oral dose pharmaceutical packaging and this could impact on prescribing habits.

Novel drug delivery critical to pharma’s future, says report

14-Dec-2010 - Pharma should forget about ‘the next blockbuster drug’ and invest more money creating novel drug delivery systems with emerging developers to enhance product value and efficacy, say researchers.

News in brief

Novartis to reduce US sales force, days after denying job cut rumours

01-Dec-2010 - Novartis will reduce its US General Medicines sales force by 1,400 employees next year in preparation for impending patent loss for key products.

Celanese rolls out new customisable EVA excipient

08-Nov-2010 - Celanese has launched a new controlled-release EVA excipient and says developing enhanced formulations is key to a drugmaker’s competitive edge in today’s pharmaceutical market.

Endeavour sees recovery in intermediates sector

28-Oct-2010 - Drug industry demand for chemical intermediates and development projects has rebounded significantly in the last 12 months according to UK group Endeavour Specialty Chemicals.

Particle Sciences boost delivery tech offering with Solumer

20-Oct-2010 - Particle Sciences (PSI) becomes provider of Solumer drug delivery tech in deal with Israeli developer SoluBest.

Respiratory drugs a particular* opportunity for processing tech says Prosonix

19-Oct-2010 - Prosonix expects high demand for innovative particle processing technologies in the $24bn (€17bn) a-year respiratory pharmaceuticals market over the next few years.

NovaDel pilot PK study compares oral spray to Viagra

18-Oct-2010 - Data from a study comparing an oral spray formulation of sildenafil citrate to Viagra has been presented by NovaDel Pharma.

IMS prediction: Emerging markets front 5-7 % rise in drug sales for 2011

13-Oct-2010 - IMS Health predicts that global drug sales will increase 5 to 7 per cent next year, driven by development of innovative pharmaceuticals and growth of emerging markets.

Venus to supply docetaxel to Thailand

29-Sep-2010 - Venus Remedies is supplying docetaxel to Thailand after a compulsory license was issued to make the drug more affordable.

Large pharma firms interested in Stirling delivery tech

27-Sep-2010 - Stirling Products is in discussions with three large pharma interesting in accessing its HDA drug delivery platform.

Sun set on helping Taro, after buying controlling stake

23-Sep-2010 - India’s Sun Pharma has finally acquired a controlling stake in Israeli generics firm Taro Pharmaceutical Industries, significantly expanding its manufacturing capacity in North America.

Oracle adds pharma PLM for drug development & production

23-Sep-2010 - Oracle is revising its lifecycle management package to streamline processes including scale-up to commercial production and QbD implementation.

Q Chip scaling up cGMP production using new funding

15-Sep-2010 - Q Chip is using new funding to scale up its Q-Sphera technology for cGMP production of sustained release peptide and protein therapeutics.

Sanofi files sBLA with FDA for intradermal influenza vaccine

14-Sep-2010 - Sanofi Pasteur has filed a sBLA with the FDA for an intradermal form of influenza vaccine Fluzone using a microinjection system.


GSK taps Lonza for bio plant knowledge; sells R&D site to Galapagos

08-Sep-2010 - GSK will work with Lonza on the development of a UK biomanufacturing plant as part of a new MAb manufacturing contract announced today.

Actavis looks to enter biosimilars through acquisition

08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.

Cipla looking at 25% Cipla Medpro investment

07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...